Park Ha Biological Technology Co Ltd (PHH)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Park Ha Biological Technology Co Ltd Stock (PHH) Company Profile

Park Ha Biological Technology Co Ltd

Consumer Defensive (250)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

PHH's Discussions on Twitter

Vergleichen Sie PHH mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
PHH Park Ha Biological Technology Co Ltd	36.00	493.20M	0	0	0	0.00
PG Procter Gamble Co	159.94	381.79B	83.93B	15.50B	15.03B	6.30
UL Unilever Plc Adr	61.13	154.84B	65.10B	6.16B	0	2.4569
CL Colgate Palmolive Co	91.30	74.51B	19.95B	2.90B	3.47B	3.54
KMB Kimberly Clark Corp	130.24	44.14B	19.75B	2.47B	2.39B	7.34
KVUE Kenvue Inc	20.98	41.32B	15.30B	1.06B	1.45B	0.55

Park Ha Biological Technology Co Ltd Aktie (PHH) Neueste Nachrichten

Finanzdaten der Park Ha Biological Technology Co Ltd-Aktie (PHH)

Es liegen keine Finanzdaten für Park Ha Biological Technology Co Ltd (PHH) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Park Ha Biological Technology Co Ltd (PHH)

Park Ha Biological Technology Co Ltd Stock (PHH) Company Profile

Vergleichen Sie PHH mit anderen Aktien

Park Ha Biological Technology Co Ltd Aktie (PHH) Neueste Nachrichten

With Beauty Farm Medical and Health Industry Inc. (HKG:2373) It Looks Like You'll Get What You Pay For - simplywall.st

Best Stocks Under $20 Right Now - Benzinga

Why Park Ha Biological Technology Co., Ltd. (PHH) is Surging in 2025 - Insider Monkey

Why These 15 Consumer Defensive Stocks Are Surging in 2025 - Insider Monkey

Park Ha Biological Technology Co Ltd (PHH) is a good investment, but the stock may be overvalued - uspostnews.com

Company’s Banking Stock: Dissecting a 131.28% Quarterly Revenue Decline Amid Growth - investchronicle.com

Park Ha Biological Technology: Growth Potential And Profitability Concerns (NASDAQ:PHH) - Seeking Alpha

12 Consumer Discretionary Stocks Moving In Friday's Intraday Session - Benzinga

Why Park Ha Biological Technology Co Ltd (PHH) Is Surging In 2025? - Insider Monkey

Why These 15 Defensive Stocks Are Surging In 2025 - Insider Monkey

12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session - Benzinga

Why Park Ha Biological Technology Co., Ltd. (PHH) Soared Last Week - MSN

10 Micro-, Small-Cap Firms Were Last Week’s Top Performers - Insider Monkey

Acid-Responsive Biocompatible Hydrogel Modulating Tumor DNA Self-Repair Collaborated with Chemotherapy for Boosting STING Pathway-Associated Immunotherapy - ACS Publications

Best Growth Stocks to Watch in April 2025 - Investopedia

Neumora Therapeutics and Other Stocks Suffer Major Losses as Market Faces Declines - HPBL

3 Growth Stocks With High Insider Ownership And 25% Earnings Growth - Simply Wall St

Northern Vietnam province urges VSIP to build high-tech park - Theinvestor.vn

D. Boral Capital Served as Underwriter to Park Ha - GlobeNewswire

The Business of Beauty Haul of Fame: Revenge of the Cheap Shampoo - The Business of Fashion

Microbot Medical Announces $7 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules - The Manila Times

Stock Market Movers Today • Top Gainers & Losers - Benzinga

Stock market today: Neumora Therapeutics -80.09%, Baird Medical Investment Holdings -44.08% among biggest losers in early trading - Business Upturn

Why MicroStrategy Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket - Benzinga

Siemens Ltd. Shows Modest Growth Amid Market Fluctuations: A Closer Look at Key Metrics - HPBL

SJVN Shares Surge After Major Power Project Deal with Bihar Government – Stock Market - HPBL

Max Healthcare Shares Climb 1.18% Amid Positive Market Sentiment – Stock Market - HPBL

IREDA Shares Surge After Strong Q3FY25 Update: A Promising Start to 2025 – Stock Market - HPBL

Asian Paints Faces Unprecedented Challenges: Stock Slides 33% in 2024 Amid Competitive Pressures - HPBL

Boeing Faces Turbulence in 2024: A Year of Setbacks and Struggles for the U.S. Aerospace Giant - HPBL

Adlai Nortye Sees Significant Growth in Short Interest Amid Stock Performance Fluctuations - HPBL

Scully Royalty Ltd. Reports Substantial Losses in Half-Year Earnings for 2024 – Stock Market - HPBL

SoundHound AI Stock Drops 7% Amid Insider Sales and Analyst Activity: What’s Next for SOUN? - HPBL

BigBear.ai Stock Soars to 19-Month High After Analysts Boost Price Target to $7 – Stock Market - HPBL

Rigetti Computing (RGTI): The Volatile Ride Ahead After a 463% Surge – Stock Market - HPBL

Lucid Group Faces Volatile Trading After Gravity SUV Delivery Launch – Stock Market - HPBL

MicroCloud Hologram Inc. Sees Surge in Trading Volume Amid Volatility: What You Need to Know - HPBL

Park Ha Biological Technology Shares Gain After IPO - MarketWatch

Stock market news: Baird Medical Investment +424.44%, Aptorum Group +292.625% among top gainers during mid day trading - Business Upturn

US Stocks Edge Higher as 2024 Closes Strong, AI and Economic Optimism Drive Gains – Stock Market - HPBL

U.S. Stock Market Drifts Higher as Wall Street Closes a Record-Breaking Year - HPBL

U.S. Stock Market Climbs Into 2025, Ending a Record-Breaking Year - HPBL

Finanzdaten der Park Ha Biological Technology Co Ltd-Aktie (PHH)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie PHH